Trial intelligence / Profile preview

CLAPPS: Pre- vs Post-incision Bupivacaine in Sacrocolpopexy

NCT04996251Phase 4Completed

Sponsor
Northwell Health
Start
Jul 2021
Primary completion
May 2023
Modality
Small Molecules
Countries
1
01

Overview

Phase 4, randomised, single-blind trial of bupivacaine in postoperative pain (2 arms), sponsored by Northwell Health. Primary endpoint: Likert-pain Scale Score on Postoperative Day One. Started Jul 2021; status: completed.

02

Drugs

bupivacaine
03

Conditions

postoperative pain

Beyond the preview

Go deeper on NCT04996251.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT04996251.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call